Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
PT Samator Indo Gas Tbk (AGII.JK)
Jakarta Selatan, ID
PT Aneka Gas Industri Tbk, an Indonesian enterprise, specializes in the production, distribution, and sale of a diverse array of industrial gases. Its extensive product line includes common atmospheric gases like oxygen, nitrogen, and argon. The company also supplies a range of specialized and mixed gas formulations, such as sulfur hexafluoride, high-purity gases, sterilization agents, compressed natural gas, environmental calibration mixtures, and gases tailored for exhaust emissions engine analysis. Synthetic gases like hydrogen, carbon monoxide, and sulfur dioxide are also part of its offerings. For the healthcare sector, the company provides medical oxygen, nitrous oxide, medical air, nitrogen, carbon dioxide, helium, lung function testing mixtures, blood analysis calibration gases, and cryopreservation gases. Furthermore, hydrocarbon gases including propane, natural gas, liquefied petroleum gas (LPG), and acetylene are available. Additional products encompass ammonia, proprietary Samator fuel gas, and rare atmospheric gases such as krypton, neon, and xenon. Beyond gases, the company offers a suite of related products and services, including medical equipment and supplies, advanced medical gas monitoring systems, on-site gas generation solutions, gas handling and cutting tools, and modular operating theater components. Comprehensive installation services are also provided. Operations are supported by a network of approximately 100 gas filling stations. Established in 1916, this venerable enterprise maintains its headquarters in Jakarta Selatan, Indonesia.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.48% | -1.44% | -8.67% | -16.72% | +73.42% | +72.33% | +136.21% | +37.69% | +151.38% | +136.21% | +136.21% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+3.5% Q1'26: +7.9% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-44.4% Q1'26: +334.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+1.9% Q1'26: -0.3% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+13.6% ★ Q1'26: +16.5% (vs Q1'25)
-
ROIC Chemicals: +3.4%+4.0% ★ Q1'26: +5.4% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×4.74× Q1'26: 5.87× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.65T
est: 1.69T (-2.3%)
|
1.84T
est: 1.84T (+0.0%)
|
2.07T
est: 1.91T (+8.6%)
|
2.20T
est: 2.19T (+0.5%)
|
2.19T
est: 2.15T (+1.7%)
|
2.74T
est: 2.61T (+5.1%)
|
2.61T
est: 2.94T (-11.2%)
|
2.82T
est: 1.08T (+161.6%)
|
3.01T
est: 3.07T (-2.0%)
|
3.26T
3.26T – 3.26T
+6.2% YoY
|
3.46T
3.46T – 3.46T
+6.3% YoY
|
| EBITDA |
541.03B
est: 521.12B (+3.8%)
|
600.40B
est: 566.76B (+5.9%)
|
641.14B
est: 588.66B (+8.9%)
|
670.03B
est: 675.88B (-0.9%)
|
752.68B
est: 663.72B (+13.4%)
|
988.70B
est: 803.89B (+23.0%)
|
855.23B
est: 907.19B (-5.7%)
|
895.40B
est: 332.72B (+169.1%)
|
839.91B
est: 906.56B (-7.4%)
|
962.39B
962.39B – 962.39B
+6.2% YoY
|
1.02T
1.02T – 1.02T
+6.3% YoY
|
| EBIT |
367.44B
est: 319.82B (+14.9%)
|
419.86B
est: 347.82B (+20.7%)
|
442.74B
est: 361.26B (+22.6%)
|
470.20B
est: 414.79B (+13.4%)
|
451.90B
est: 407.33B (+10.9%)
|
636.12B
est: 493.35B (+28.9%)
|
472.92B
est: 556.75B (-15.1%)
|
504.64B
est: 204.19B (+147.1%)
|
409.39B
est: 537.53B (-23.8%)
|
570.64B
570.64B – 570.64B
+6.2% YoY
|
606.37B
606.37B – 606.37B
+6.3% YoY
|
| Net Income |
54.89B
est: 71.81B (-23.6%)
|
85.57B
est: 99.97B (-14.4%)
|
99.73B
est: 109.48B (-8.9%)
|
100.97B
est: 105.80B (-4.6%)
|
96.41B
est: 63.98B (+50.7%)
|
204.18B
est: 131.87B (+54.8%)
|
88.38B
est: 180.93B (-51.2%)
|
165.41B
|
58.38B
est: 80.35B (-27.3%)
|
108.87B
108.87B – 108.87B
+35.5% YoY
|
159.16B
159.16B – 159.16B
+46.2% YoY
|
| SGA |
185.33B
est: 212.61B (-12.8%)
|
194.30B
est: 231.22B (-16.0%)
|
250.09B
est: 240.16B (+4.1%)
|
265.85B
est: 275.74B (-3.6%)
|
225.87B
est: 270.78B (-16.6%)
|
294.78B
est: 327.97B (-10.1%)
|
313.43B
est: 370.11B (-15.3%)
|
393.65B
est: 135.74B (+190.0%)
|
521.67B
est: 429.15B (+21.6%)
|
455.58B
455.58B – 455.58B
+6.2% YoY
|
484.11B
484.11B – 484.11B
+6.3% YoY
|
| EPS |
22.60
est: 23.42 (-3.5%)
|
27.90
est: 32.60 (-14.4%)
|
32.52
est: 35.70 (-8.9%)
|
32.93
est: 34.50 (-4.6%)
|
31.59
est: 20.86 (+51.4%)
|
66.90
est: 43.00 (+55.6%)
|
32.63
est: 59.00 (-44.7%)
|
54.01
|
19.04
est: 26.20 (-27.3%)
|
35.50
35.50 – 35.50
+35.5% YoY
|
51.90
51.90 – 51.90
+46.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-15 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ahmad Sururi | Head of Production & Process Improvement | — | — |
| Budi Susanto | Bulk & Onsite Director and Director | — | male |
| Chusnul Amin | Head of Maintenance & Plant Reliability | — | — |
| Djanarko Tjandra | International Alliances & Business Development Director and Director | — | male |
| Ferryawan Utomo | COO & Vice President Commissioner | — | male |
| Ganggar Dwi Christiawan | Head of Internal Audit Unit | — | — |
| Imelda Mulyani Harsono | Risk, Technology & Compliance Director, Corporate Secretary and VP Director | — | female |
| James Waskito Sasongko | Chief of People & Organization Transformation | — | — |
| Nini Liemijanto | Finance & Accounting Director and Commissioner | — | female |
| Octavianus Santoso Rastanto | Technical & Sustainability Director | — | male |
| Rachmat Harsono | President Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AGII.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
